Posters

      Development of a “Contrast and Gene Set” Toolkit‐ Integrated Database Platform for Downstream Computational Analysis Supporting Biological Interpretation of Gene Expression Data

      Poussin, C.; L. Hermida,; Sewer, A.; Ansari, S.; Gubian, S.; Hoeng, J.

      Conference date
      Aug 28, 2011
      Conference name
      International Conference in Systems Biology (ICSB) 2011
      Link to more information
      Topic
      Summary

      Background: In transcriptomics, the identification of differentially expressed genes (DEG) when studying effect(s)/contrast(s) of interest constitutes the central component for further downstream computational analysis (e.g., gene over-representation/enrichment analysis or reverse engineering) leading to mechanistic insights. Therefore, it is essential to adequately store contrast data and automatically extract gene sets from these DEG lists in order to efficiently support these downstream activities and further leverage data on a long-term basis. Methods: We report here the development of a contrast and gene set toolkit-integrated database enabling: 1) storage of contrast data and metadata (associated with the analysis process) in a simple and standard format (IDMaps); 2) automatic ID conversion of data via a mapping and collapsing methodology using the latest public annotations (NCBI gene database); 3) automatic extraction and storage of 3 gene sets (significantly up-regulated, down-regulated, and both directions) derived from stored contrasts; and 4) integration of extensible downstream computational analysis functionality. Gene set enrichment analysis is currently integrated as a downstream method in the toolkit, which is built within galaxy, an open-source workflow management and data integration system. In addition, the toolkit provides both web access and programmatic access via R library. Results: Several examples are presented to show the range of application and the advantages of the toolkit; for instance, internal and external dataset comparison, species and system (in vitro / in vivo) translation analysis, and biological interpretation in a FDR threshold-free and platform-independent manner. Conclusion: The contrast and gene set toolkit-integrated database platform provides a unique and flexible environment to support downstream computational analysis enabling biological interpretation of data. The system has been designed in order to supply the researcher with a simple, efficient, and extensible solution to store and exploit analyzed data in a sustainable manner. 

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.